Comments
Loading...

AC Immune Analyst Ratings

ACIUNASDAQ
Logo brought to you by Benzinga Data
Consensus Rating1
Buy
Highest Price Target1
$16.00
Lowest Price Target1
$8.00
Consensus Price Target1
$11.33

AC Immune Analyst Ratings and Price Targets | NASDAQ:ACIU | Benzinga

AC Immune SA has a consensus price target of $11.33 based on the ratings of 3 analysts. The high is $16 issued by HC Wainwright & Co. on March 14, 2025. The low is $8 issued by BTIG on May 31, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 14, 2025, November 15, 2024, and November 6, 2024, respectively. With an average price target of $16 between HC Wainwright & Co., there's an implied 712.18% upside for AC Immune SA from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Nov 24
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
BTIG
SVB Leerink

1calculated from analyst ratings

Analyst Ratings for AC Immune

Buy NowGet Alert
03/14/2025Buy Now712.18%HC Wainwright & Co.
Andrew Fein56%
$16 → $16ReiteratesBuy → BuyGet Alert
11/15/2024Buy Now712.18%HC Wainwright & Co.
Andrew Fein56%
$16 → $16ReiteratesBuy → BuyGet Alert
11/06/2024Buy Now712.18%HC Wainwright & Co.
Andrew Fein56%
$16 → $16ReiteratesBuy → BuyGet Alert
09/18/2024Buy Now712.18%HC Wainwright & Co.
Andrew Fein56%
$16 → $16ReiteratesBuy → BuyGet Alert
05/31/2024Buy Now306.09%BTIG
Thomas Shrader40%
→ $8Initiates → BuyGet Alert
03/15/2024Buy Now712.18%HC Wainwright & Co.
Andrew Fein56%
$16 → $16ReiteratesBuy → BuyGet Alert
11/13/2023Buy Now712.18%HC Wainwright & Co.
Andrew Fein56%
→ $16ReiteratesBuy → BuyGet Alert
08/07/2023Buy Now712.18%HC Wainwright & Co.
Andrew Fein56%
→ $16ReiteratesBuy → BuyGet Alert
06/28/2023Buy Now712.18%HC Wainwright & Co.
Andrew Fein56%
→ $16ReiteratesBuy → BuyGet Alert
05/01/2023Buy Now712.18%HC Wainwright & Co.
Andrew Fein56%
→ $16Reiterates → BuyGet Alert
04/19/2023Buy Now712.18%HC Wainwright & Co.
Andrew Fein56%
→ $16Reiterates → BuyGet Alert
03/17/2023Buy Now712.18%HC Wainwright & Co.
Andrew Fein56%
→ $16Reiterates → BuyGet Alert
07/11/2022Buy Now407.61%SVB Leerink
Marc Goodman73%
$15 → $10MaintainsOutperformGet Alert

FAQ

Q

What is the target price for AC Immune (ACIU) stock?

A

The latest price target for AC Immune (NASDAQ:ACIU) was reported by HC Wainwright & Co. on March 14, 2025. The analyst firm set a price target for $16.00 expecting ACIU to rise to within 12 months (a possible 712.18% upside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for AC Immune (ACIU)?

A

The latest analyst rating for AC Immune (NASDAQ:ACIU) was provided by HC Wainwright & Co., and AC Immune reiterated their buy rating.

Q

When was the last upgrade for AC Immune (ACIU)?

A

There is no last upgrade for AC Immune

Q

When was the last downgrade for AC Immune (ACIU)?

A

There is no last downgrade for AC Immune.

Q

When is the next analyst rating going to be posted or updated for AC Immune (ACIU)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AC Immune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AC Immune was filed on March 14, 2025 so you should expect the next rating to be made available sometime around March 14, 2026.

Q

Is the Analyst Rating AC Immune (ACIU) correct?

A

While ratings are subjective and will change, the latest AC Immune (ACIU) rating was a reiterated with a price target of $16.00 to $16.00. The current price AC Immune (ACIU) is trading at is $1.97, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.